Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBig Technologies Regulatory News (BIG)

Share Price Information for Big Technologies (BIG)

Share Price is delayed by 15 minutes
Get Live Data
104.50    0.00 (0.00%)
Bid:
104.50
Ask:
106.00
Spread: 1.50 (1.435%)
Market Cap: £305.38m
BIG Live PriceLast checked at - London Stock Exchange

Intraday Big Technologies Share Chart

AGM Statement

28 May 2024 07:00

RNS Number : 8552P
Big Technologies PLC
28 May 2024
Β 

Β 

28 May 2024

Β 

Big Technologies plc

("Big Technologies" or the "Company" and the "Group")

AGM Statement

Big Technologies plc, theΒ UK-based, remote people monitoring technology company provides the following trading update ahead of its Annual General Meeting ("AGM") in London later today.

At the meeting, Simon Collins, Chair of Big Technologies plc will make the following statement:

"Since the announcement of our full year results in March 2024, the Board is pleased to report that the Group continues to perform in line with our expectations for the current year.

In the four months ending April 2024, we have recorded unaudited consolidated revenue of Β£18.5 million, which is unchanged from that achieved over the same period in 2023. As previously announced, revenues from our contract in Colombia will end in the first half of the year as the customer makes the transition to a new supplier. As a result, revenue is expected to be lower in the second half of the year, versus the first half.

In the US we have started to see some early successes and have added a number of smaller accounts as our new business development efforts gain traction. Overall, the forward visibility from our core global customer base remains excellent - 86% of the revenue from our largest customers is contracted beyond the end of 2026.

Our financial expectations for 2024 are unchanged and the Board remains confident of delivering results in line with current market expectations(1).

Our products and technology deliver benefits for society across the globe. In the criminal justice sector our products facilitate a shift towards rehabilitative community-based sentencing which reduces recidivism and keep communities safer. In the remote care sector our technology helps people live happier, healthier and more independent lives.

Drivers for continued growth across both sectors remain strong in the medium-term. With our clear strategy and market-leading products, we are well positioned to generate strong cash flow and expect a return to growth in 2025 and beyond."

(1) Latest company compiled view of market expectations show adjusted EBITDA of Β£27.0 million to Β£29.5 million (stated before share-based payments).

Β For further information please contact:

Β 

Big Technologies

+44 (0) 19 2360 1910

Sara MurrayΒ (Chief Executive Officer)

Daren MorrisΒ (Chief Financial Officer)

Zeus (Nominated Adviser and Sole Broker)

+44 (0) 20 3829 5000

Dan Bate / Kieran Russell (Investment Banking)

Benjamin RobertsonΒ (Equity Capital Markets)

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
AGMSEUSULELSEII
Date   Source Headline
27th May 20267:00 amRNSNotice of AGM
30th Mar 20267:00 amRNSAudited Results for the year to 31 December 2025
26th Feb 20267:00 amRNSHolding(s) in Company
3rd Feb 20267:00 amRNSBoard Changes
2nd Feb 20267:00 amRNSHolding(s) in Company
27th Jan 20267:00 amRNSFull Year Trading Update
19th Jan 20267:00 amRNSFurther Litigation Update
10th Dec 20259:41 amRNSHolding(s) in Company
9th Dec 20259:42 amRNSHolding(s) in Company
8th Dec 20257:00 amRNSTrading Update
3rd Nov 20252:54 pmRNSDirector and PDMR Dealings
16th Oct 20257:01 amRNSWithdrawal of General Meeting Requisition Notice
16th Oct 20257:00 amRNSBoard Changes
3rd Oct 20257:00 amRNSBoard Changes
30th Sep 20257:00 amRNSInterim Results for the 6 months to 30 June 2025
26th Sep 20257:00 amRNSNotice of Requisition of a General Meeting
12th Sep 20257:00 amRNSLitigation Update
20th Aug 20257:00 amRNSChange of Website Address
6th Aug 20257:00 amRNSBoard Change and Issue of Shares
1st Aug 20257:00 amRNSIssue of Shares
28th Jul 20257:00 amRNSBoard Changes
22nd Jul 20257:00 amRNSTrading Update
18th Jun 20252:53 pmRNSResult of AGM and Litigation Update
13th Jun 20258:12 amRNSPublication of Letter to Shareholders
10th Jun 20251:27 pmRNSSuspension of Voting Rights and Letter Response
5th Jun 20257:00 amRNSLitigation Update
22nd May 20259:45 amRNSDirector Dealings
22nd May 20257:00 amRNS2024 Audited Results and Notice of AGM
16th May 20257:00 amRNSAppointment of Joint Corporate Broker
8th May 20257:00 amRNSBoard and Management Changes and Trading Update
7th Apr 20257:00 amRNSAppointment of Non Executive Director
3rd Apr 20257:00 amRNSUpdate re: CEO Dismissal
1st Apr 20257:00 amRNS-RContract Award
1st Apr 20257:00 amRNSDirectorate Change
1st Apr 20257:00 amRNSTransaction in Own Shares
31st Mar 20255:20 pmRNSCEO Dismissal and Commencement of Litigation
27th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 20257:00 amRNSTransaction in Own Shares
24th Mar 20257:00 amRNSHolding(s) in Company
24th Mar 20257:00 amRNSTransaction in Own Shares
21st Mar 202511:13 amRNSLitigation Update
21st Mar 20257:00 amRNSTransaction in Own Shares
20th Mar 20257:00 amRNSTransaction in Own Shares
19th Mar 20257:00 amRNSTransaction in Own Shares
18th Mar 202512:51 pmRNSCEO Suspension
18th Mar 20257:00 amRNSTransaction in Own Shares
14th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSTransaction in Own Shares
12th Mar 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.